A New Vaccine to Protect Honey Bees from American Foulbrood Disease

The United States Department of Agriculture (USDA) has granted a conditional license for a vaccine produced by Dalan Animal Health, a U.S. biotechnology company, to help protect honey bees from American foulbrood disease. U.S. health authorities have approved this vaccine, the first of its kind in the world, to protect bees from diseases that routinely affect them, impacting honey production. Anit Kleiser, the company's CEO, stated that the new vaccine represents "a breakthrough in honey bee protection," adding that it "will change the way we care for these insects, affecting food production on a global scale."